{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-023066","form_type":"8-K","ticker":"FDUS","cik":"0001513363","company_name":"FIDUS INVESTMENT Corp","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.440692+00:00","generated_at":"2026-06-05T06:34:39.802458+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Fidus Q4 adjusted NII $0.65/share; declares $0.65 Q1 dividend","bullets":["Q4 total investment income $36.3M, net investment income $16.9M ($0.58/share), adjusted NII $18.8M ($0.65/share).","FY2023 total investment income $130.1M, NII $65.1M ($2.47/share), adjusted NII $67.5M ($2.56/share), up 36.2% YoY per share.","NAV per share $19.37 as of Dec 31, 2023; portfolio fair value $957.9M across 81 active companies.","Board declared Q1 2024 dividend of $0.65/share ($0.43 base + $0.22 supplemental), payable March 27 to holders of record March 20.","Subsequent events: invested $5M in Janus Health, exited Applied Data for $1.5M realized gain, repaid $35M SBA debentures."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-023066","json":"https://secwatch.observer/filing/0000950170-24-023066.json","markdown":"https://secwatch.observer/filing/0000950170-24-023066.md","text":"https://secwatch.observer/filing/0000950170-24-023066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513363/000095017024023066/0000950170-24-023066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513363/000095017024023066/fdus-20230302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T06:34:39.802458+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19f7fd579e8082f05f4e383392a1c387bfbafd2b","claim":"FIDUS INVESTMENT Corp reported the full year ended December 31, 2023 results: revenue $130.1 million, net income $65.1 million, EPS $2.47 per share.","evidence_excerpt":"Full Year 2023 Financial Highlights • Total investment income of $130.1 million • Net investment income of $65.1 million, or $2.47 per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513363/000095017024023066/0000950170-24-023066-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2023"},{"label":"Revenue","value":"$130.1 million"},{"label":"Net income","value":"$65.1 million"},{"label":"EPS","value":"$2.47 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"cdf856a7e408f20ba3d892ccaf136b4388928b78","claim":"FIDUS INVESTMENT Corp reported the fourth quarter ended December 31, 2023 results: revenue $36.3 million, net income $16.9 million, EPS $0.58 per share.","evidence_excerpt":"Fourth Quarter 2023 Financial Highlights • Total investment income of $36.3 million • Net investment income of $16.9 million, or $0.58 per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513363/000095017024023066/0000950170-24-023066-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$36.3 million"},{"label":"Net income","value":"$16.9 million"},{"label":"EPS","value":"$0.58 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}